KPIs & Operating Metrics(New)
Balance Sheet
Accounts PayablesAccumulated ExpensesAssetsBuildingsCash & Current InvestmentsCash & EquivalentsCommon EquityConstruction in ProgressCurrent AssetsFinished GoodsGoodwillGoodwill & IntangiblesIntangiblesInventoryLand & ImprovementsLiabilities and Shareholders EquityLong-Term Deferred TaxMinority InterestNon-Current AssetsNon-Current DebtNon-Current Deferred Tax LiabilityOther Accumulated ExpensesOther Non-Current AssetsOther Non-Current LiabilitiesPayablesPrepaid AssetsProperty, Plant & Equipment (Net)Raw MaterialsReceivablesReceivables - NetRetained EarningsShareholder's EquityShort term DebtTotal Current LiabilitiesTotal DebtTotal LiabilitiesTotal Non-Current LiabilitiesTreasury SharesWork In Process
Cash Flow Statement
Daily Values
Growth Metrics
Income Statement
Others
Ratios

Boston Scientific (BSX) Total Liabilities (2016 - 2025)

Historic Total Liabilities for Boston Scientific (BSX) over the last 17 years, with Q4 2025 value amounting to $19.2 billion.

  • Boston Scientific's Total Liabilities rose 1040.13% to $19.2 billion in Q4 2025 from the same period last year, while for Dec 2025 it was $19.2 billion, marking a year-over-year increase of 1040.13%. This contributed to the annual value of $19.2 billion for FY2025, which is 1040.13% up from last year.
  • As of Q4 2025, Boston Scientific's Total Liabilities stood at $19.2 billion, which was up 1040.13% from $19.1 billion recorded in Q3 2025.
  • Boston Scientific's Total Liabilities' 5-year high stood at $19.2 billion during Q4 2025, with a 5-year trough of $14.3 billion in Q3 2022.
  • Its 5-year average for Total Liabilities is $16.2 billion, with a median of $15.6 billion in 2022.
  • As far as peak fluctuations go, Boston Scientific's Total Liabilities skyrocketed by 3554.7% in 2021, and later tumbled by 718.78% in 2022.
  • Over the past 5 years, Boston Scientific's Total Liabilities (Quarter) stood at $15.6 billion in 2021, then fell by 4.56% to $14.9 billion in 2022, then grew by 4.77% to $15.6 billion in 2023, then rose by 11.44% to $17.4 billion in 2024, then grew by 10.4% to $19.2 billion in 2025.
  • Its Total Liabilities was $19.2 billion in Q4 2025, compared to $19.1 billion in Q3 2025 and $18.9 billion in Q2 2025.